Frequently Asked Questions

Your Queries Answered

We understand that you may have questions about bacteriophage therapies and their availability. This section aims to clarify any doubts and provide essential information about our biobank and services.

What are bacteriophages?

Bacteriophages are virulent viruses that specifically target and kill bacteria. They serve as a promising alternative treatment for bacterial infections, particularly those resistant to conventional antibiotics, and are integral to our therapy development.

How does the biobank work?

Our open-access phage biobank enables researchers and clinicians to access safe and effective phage stock. This system promotes collaboration while ensuring responsible use of bacteriophage technology.

Who can access the therapies?

Therapies from our biobank are designed for healthcare professionals, researchers, and institutions around the world, aiming to expand access to effective treatment options for patients suffering from drug-resistant infections.